Cyclacel Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of CYCC for the last quarter is 4.00 k USD, and it's 86.21% lower compared to the previous quarter. The net income of Q2 24 is -3.26 M USD.